Mechanistic and inhibition studies on isocitrate dehydrogenase 1

Mechanistic and inhibition studies on isocitrate dehydrogenase 1

<p>Genes encoding for IDH1 and IDH2 are frequently mutated in multiple cancer types including gliomas and AML. IDH variants, notably R132H IDH1, result in a gain-offunction leading to substantially enhanced production of the ‘oncometabolite’, 2- hydroxyglutarate. Drug development by pharmaceut...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteur:	Liu, S
Andere auteurs:	Schofield, C
Formaat:	Thesis
Taal:	English
Gepubliceerd in:	2019

Gelijkaardige items

The studies on the mechanism and inhibition of Isocitrate Dehydrogenases
door: Liu, X
Gepubliceerd in: (2022)

Mutation of Isocitrate Dehydrogenase 1 in Cholangiocarcinoma Impairs Tumor Progression by Inhibiting Isocitrate Metabolism
door: Li Su, et al.
Gepubliceerd in: (2020-04-01)

How robust are the data in vorasidenib for isocitrate dehydrogenase-1 or isocitrate dehydrogenase-2 mutant low-grade glioma?
door: Eric T Wong
Gepubliceerd in: (2023-01-01)

Highlighting the mechanistic role of Olutasidenib (FT-2102) in the selective inhibition of mutated isocitrate dehydrogenase 1 (mIDH1) in cancer therapy
door: Elliasu Y. Salifu, et al.
Gepubliceerd in: (2022-01-01)

Differentiating inhibition selectivity and binding affinity of isocitrate dehydrogenase 1 variant inhibitors
door: Liu, S, et al.
Gepubliceerd in: (2023)

Roles of metal ions in the selective inhibition of oncogenic variants of isocitrate dehydrogenase 1
door: Liu, S, et al.
Gepubliceerd in: (2021)

Inhibitors of mutant isocitrate dehydrogenase for isocitrate dehydrogenase-mutant gliomas: A new standard of care?
door: Emilie Le Rhun, et al.
Gepubliceerd in: (2024-01-01)

Roles of metal ions in the selective inhibition of oncogenic variants of isocitrate dehydrogenase 1
door: Shuang Liu, et al.
Gepubliceerd in: (2021-11-01)

The regulatory mechanisms and inhibitors of isocitrate dehydrogenase 1 in cancer
door: Yang Liu, et al.
Gepubliceerd in: (2023-04-01)

Isocitrate dehydrogenase inhibitors in acute myeloid leukemia
door: Xiaoyan Liu, et al.
Gepubliceerd in: (2019-10-01)

Studies on human cancer variant and mycobacterial isocitrate dehydrogenases
door: Reinbold, R
Gepubliceerd in: (2021)

The Role of Isocitrate Dehydrogenases in Direct Reprogramming to Cardiomyocytes
door: Tomoaki Ishida, et al.
Gepubliceerd in: (2021-12-01)

Isocitrate Dehydrogenase 1 and 2 Mutations in Pediatric Neuroblastoma Patients
door: Emre LEVENTOGLU, et al.
Gepubliceerd in: (2023-06-01)

Mutasi Isocitrate Dehydrogenase 1 dan 2 pada Glioma
door: Ni Putu Sriwidyani
Gepubliceerd in: (2020-12-01)

Functional analysis of mutations in isocitrate dehydrogenase involved in gliomagenesis
door: Krell, D
Gepubliceerd in: (2014)

Metabolic adaptations in cancers expressing isocitrate dehydrogenase mutations
door: Hvinden, IC, et al.
Gepubliceerd in: (2021)

Isocitrate dehydrogenase gene variants in cancer and their clinical significance
door: Cadoux-Hudson, T, et al.
Gepubliceerd in: (2021)

Cytosolic NADP-isocitrate dehydrogenase in Arabidopsis leaves and roots
door: M. Leterrier, et al.
Gepubliceerd in: (2012-12-01)

Isocitrate Dehydrogenase Inhibitors in Glioma: From Bench to Bedside
door: Merve Hazal Ser, et al.
Gepubliceerd in: (2024-05-01)

Mutant Isocitrate Dehydrogenase Inhibitors as Targeted Cancer Therapeutics
door: Danielle Golub, et al.
Gepubliceerd in: (2019-05-01)

Isocitrate dehydrogenases in physiology and cancer: biochemical and molecular insight
door: Hamoud Al-Khallaf
Gepubliceerd in: (2017-08-01)

Research Progress of Isocitrate Dehydrogenase Gene Mutation Therapy
door: LIN Meijia, et al.
Gepubliceerd in: (2023-03-01)

Isocitrate dehydrogenase 1 and 2 genes mutations and MGMT methylation in gliomas
door: D. V. Tabakov, et al.
Gepubliceerd in: (2017-04-01)

Advances in Immune Microenvironment and Immunotherapy of Isocitrate Dehydrogenase Mutated Glioma
door: Dongming Yan, et al.
Gepubliceerd in: (2022-06-01)

Isocitrate dehydrogenase variants in cancer — Cellular consequences and therapeutic opportunities
door: Liu, S, et al.
Gepubliceerd in: (2020)

Structure and allosteric regulation of human NAD-dependent isocitrate dehydrogenase
door: Pengkai Sun, et al.
Gepubliceerd in: (2020-12-01)

Isocitrate protects DJ-1 null dopaminergic cells from oxidative stress through NADP+-dependent isocitrate dehydrogenase (IDH).
door: Jinsung Yang, et al.
Gepubliceerd in: (2017-08-01)

Isocitrate Dehydrogenase Mutations in Glioma: Genetics, Biochemistry, and Clinical Indications
door: Yang Liu, et al.
Gepubliceerd in: (2020-08-01)

Discovery of novel enasidenib analogues targeting inhibition of mutant isocitrate dehydrogenase 2 as antileukaemic agents
door: Ahmed F. Khalil, et al.
Gepubliceerd in: (2023-12-01)

Isocitrate dehydrogenase 1 mutation subtypes at site 132 and their translational potential in glioma
door: Victor M Lu, et al.
Gepubliceerd in: (2018-01-01)

Isocitrate dehydrogenase 1 mutation is associated with reduced levels of inflammation in glioma patients
door: Auezova R, et al.
Gepubliceerd in: (2019-04-01)

A novel isocitrate dehydrogenase 1 G131D mutation in glioblastoma
door: Lei-Ming Wang, et al.
Gepubliceerd in: (2021-02-01)

The Role of Mitochondrial NADPH-Dependent Isocitrate Dehydrogenase in Cancer Cells
door: Katarína Smolková, et al.
Gepubliceerd in: (2012-01-01)

Cytosolic Isocitrate Dehydrogenase from Arabidopsis thaliana Is Regulated by Glutathionylation
door: Adnan Khan Niazi, et al.
Gepubliceerd in: (2019-01-01)

Research Progress and Prospects of Isocitrate Dehydrogenase Gene Mutation in Chondrosarcoma
door: ZHAO Jingjing, ZHANG Zhihong, ZHEN Junping
Gepubliceerd in: (2024-04-01)

Identification of potential target genes for isocitrate dehydrogenase mutations in cholangiocarcinoma
door: WANG Di, LI Qing, TONG Wei-min, NIU Ya-mei
Gepubliceerd in: (2020-04-01)

Isocitrate dehydrogenase 1 Gene Mutation Is Associated with Prognosis in Clinical Low-Grade Gliomas.
door: Ming-Yang Li, et al.
Gepubliceerd in: (2015-01-01)

Stochastic Microsensors Based on Carbon Nanotubes for Molecular Recognition of the Isocitrate Dehydrogenases 1 and 2
door: Raluca-Ioana Stefan-van Staden, et al.
Gepubliceerd in: (2022-01-01)

Isocitrate dehydrogenase 1 mutation in cholangiocarcinoma impairs tumor progression by sensitizing cells to ferroptosis
door: Su Li, et al.
Gepubliceerd in: (2022-05-01)

Investigating isocitrate dehydrogenase mutations in cancer using new metabolomics methods
door: Walsby-Tickle, J
Gepubliceerd in: (2020)